Villere St Denis J & CO LLC Abbott Laboratories Transaction History

Villere St Denis J & CO LLC

  • $1.17 Billion
  • Q1 2024

A detailed history of Villere St Denis J & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Villere St Denis J & CO LLC holds 256,310 shares of ABT stock, worth $26.1 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares
256,310
Previous 180,490 42.01%
Holding current value
$26.1 Million
Previous $19.9 Million 46.64%
% of portfolio
2.48%
Previous 1.74%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
BUY
$109.52 - $120.96 $8.3 Million - $9.17 Million
75,820 Added 42.01%
256,310 $29.1 Million
Q4 2023

Jan 25, 2024
SELL
$90.19 - $110.4 $1.68 Million - $2.06 Million
-18,620 Reduced 9.35%
180,490 $19.9 Million
Q3 2023

Oct 20, 2023
SELL
$95.53 - $114.62 $359,383 - $431,200
-3,762 Reduced 1.85%
199,110 $19.3 Million
Q2 2023

Jul 18, 2023
SELL
$100.78 - $112.29 $272,307 - $303,407
-2,702 Reduced 1.31%
202,872 $22.1 Million
Q1 2023

Apr 25, 2023
SELL
$96.86 - $114.01 $44,652 - $52,558
-461 Reduced 0.22%
205,574 $20.8 Million
Q4 2022

Jan 18, 2023
SELL
$95.06 - $111.52 $348,299 - $408,609
-3,664 Reduced 1.75%
206,035 $22.6 Million
Q3 2022

Oct 17, 2022
SELL
$96.76 - $112.03 $9,676 - $11,203
-100 Reduced 0.05%
209,699 $20.3 Million
Q2 2022

Jul 18, 2022
BUY
$102.07 - $123.37 $232,923 - $281,530
2,282 Added 1.1%
209,799 $22.8 Million
Q1 2022

Apr 19, 2022
BUY
$114.02 - $139.04 $2.03 Million - $2.47 Million
17,775 Added 9.37%
207,517 $24.6 Million
Q4 2021

Jan 19, 2022
SELL
$115.53 - $141.46 $944,226 - $1.16 Million
-8,173 Reduced 4.13%
189,742 $26.7 Million
Q3 2021

Oct 19, 2021
SELL
$116.66 - $129.06 $291,066 - $322,004
-2,495 Reduced 1.24%
197,915 $23.4 Million
Q2 2021

Jul 19, 2021
SELL
$105.79 - $124.53 $77,226 - $90,906
-730 Reduced 0.36%
200,410 $23.2 Million
Q1 2021

Apr 19, 2021
SELL
$108.84 - $128.23 $315,636 - $371,866
-2,900 Reduced 1.42%
201,140 $24.1 Million
Q4 2020

Jan 26, 2021
SELL
$105.0 - $114.42 $182,700 - $199,090
-1,740 Reduced 0.85%
204,040 $22.3 Million
Q3 2020

Oct 27, 2020
BUY
$91.64 - $111.29 $203,899 - $247,620
2,225 Added 1.09%
205,780 $22.4 Million
Q2 2020

Jul 29, 2020
SELL
$76.57 - $98.0 $313,937 - $401,800
-4,100 Reduced 1.97%
203,555 $18.6 Million
Q1 2020

Apr 30, 2020
SELL
$62.82 - $91.86 $25,128 - $36,744
-400 Reduced 0.19%
207,655 $16.4 Million
Q4 2019

Jan 28, 2020
SELL
$78.51 - $87.4 $29,048 - $32,338
-370 Reduced 0.18%
208,055 $18.1 Million
Q3 2019

Oct 22, 2019
SELL
$81.84 - $88.74 $4,092 - $4,437
-50 Reduced 0.02%
208,425 $17.4 Million
Q2 2019

Jul 31, 2019
SELL
$72.88 - $85.0 $236,859 - $276,250
-3,250 Reduced 1.54%
208,475 $17.5 Million
Q1 2019

May 01, 2019
BUY
$66.22 - $80.06 $392,022 - $473,955
5,920 Added 2.88%
211,725 $16.9 Million
Q4 2018

Jan 22, 2019
SELL
$65.56 - $74.27 $125,219 - $141,855
-1,910 Reduced 0.92%
205,805 $14.9 Million
Q3 2018

Oct 30, 2018
SELL
$60.81 - $73.36 $1.38 Million - $1.67 Million
-22,700 Reduced 9.85%
207,715 $15.2 Million
Q2 2018

Jul 31, 2018
SELL
$57.57 - $63.54 $250,429 - $276,399
-4,350 Reduced 1.85%
230,415 $14.1 Million
Q1 2018

May 02, 2018
SELL
$56.27 - $63.62 $939,709 - $1.06 Million
-16,700 Reduced 6.64%
234,765 $14.1 Million
Q4 2017

Jan 25, 2018
SELL
$53.68 - $57.47 $566,055 - $606,021
-10,545 Reduced 4.02%
251,465 $14.4 Million
Q3 2017

Oct 31, 2017
BUY
$48.06 - $53.64 $12.6 Million - $14.1 Million
262,010
262,010 $14 Million

Others Institutions Holding ABT

# of Institutions
3,131
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $178B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Villere St Denis J & CO LLC Portfolio

Follow Villere St Denis J & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Villere St Denis J & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email